Related Experiment Video
Updated: Jan 4, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Fever-Associated Supraventricular Tachycardia after 4CMenB Vaccination in an Infant
Erdem Gönüllü1, Burcu Topçu1, Naci Öner2
1Memorial Ataşehir Hospital, Department of Pediatrics, 34758 Istanbul, Turkey.
Insights
The four-component meningococcal serogroup B vaccine (4CMenB) was administered to a girl who developed supraventricular tachycardia (SVT). This is the first reported case of SVT following 4CMenB vaccination.
Area of Science:
- Vaccinology
- Pediatric Cardiology
- Infectious Diseases
Background:
- Meningococcal serogroup B infections pose a significant public health risk.
- The four-component meningococcal serogroup B vaccine (4CMenB, Bexsero) is a novel protein-based vaccine designed to prevent Neisseria meningitidis serogroup B infections.
Observation:
- A case report details a young girl who experienced fever and supraventricular tachycardia (SVT) 6-8 hours post-second dose of the 4CMenB vaccine.
- The SVT episode required multiple doses of adenosine for termination.
Findings:
- This case represents the first documented instance of ECG-proven SVT occurring after 4CMenB vaccination.
- The patient remained SVT-free during a three-month follow-up period.
Implications:
- Healthcare providers should consider SVT in the differential diagnosis of persistent tachycardia following 4CMenB vaccination, even in the presence of fever.
- This case highlights a potential, albeit rare, adverse event associated with meningococcal serogroup B vaccination, necessitating further surveillance and research.
Abstract:
Meningococcal serogroup B vaccine 4CMenB (Bexsero) is a new four-component protein vaccine developed to prevent Neisseria meningitidis serogroup B infections. Case. We report a girl with fever and supraventricular tachycardia (SVT) 6-8 hours after the second dose of 4CMenB. SVT was unresponsive to the first dose of adenosine but terminated after the fourth dose of adenosine. During three months of follow-up, she was free of further SVT attacks. Conclusion. This is the first report of ECG-proven SVT after 4CMenB vaccination. Even if fever is coexistent, SVT should be considered after persistent tachycardia and 4CMenB vaccination.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Increased Body Temperature
Vaccinations
Types of Fever
Here are the different types of fever:
Dysrhythmias III: Characteristics of Dysrhythmias
Patterns of Fever
Myocarditis III: Medical Management